Real-time, in vivo measurement of tissular pO2 through the delayed fluorescence of endogenous protoporphyrin IX during photodynamic therapy

Journal of Biomedical Optics

Volumn 17, Issue 11, 2012, Pages

  Piffaretti, Filippo ^a   Novello, Anna Maria ^a   Kumar, Rajendran Senthil ^a   Forte, Eddy ^a   Paulou, Cédric ^a   Nowak Sliwinska, Patrycja ^a   Van Den Bergh, Hubert ^a   Wagnières, Georges ^a  

^a EPFL   (Switzerland)

Author keywords

delayed fluorescence; oxygen partial pressure; photodynamic therapy; protoporphyrin IX; tumor

Indexed keywords

AMINOLEVULINIC ACID; CHORIO-ALLANTOIC MEMBRANES; CLINICAL MEASUREMENTS; CLINICAL USE; DELAYED FLUORESCENCE; IN-VIVO MEASUREMENT; OXYGEN CONCENTRATIONS; OXYGEN PARTIAL PRESSURE; PROTOPORPHYRIN IX; REAL TIME; TIME-RESOLVED; VASCULAR DAMAGE;

ANIMALS; PARTIAL PRESSURE; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; PORPHYRINS; POSITIVE IONS; TUMORS;

FLUORESCENCE;

AMINOLEVULINIC ACID; OXYGEN; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ANIMAL; ARTICLE; CHEMISTRY; CHICK EMBRYO; CHORIOALLANTOIS; DRUG EFFECT; FLUORESCENCE; KINETICS; LIGHT RELATED PHENOMENA; METABOLISM; PHOTOCHEMOTHERAPY; TISSUE DISTRIBUTION; TOPICAL DRUG ADMINISTRATION; VASCULARIZATION;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; FLUORESCENCE; KINETICS; OPTICAL PHENOMENA; OXYGEN; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; TISSUE DISTRIBUTION;

EID: 84870609804     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.17.11.115007     Document Type: Article

References (57)

1. Agostinis P., et al., " Photodynamic therapy of cancer: an update.," CA Cancer J. Clin. 61 (4), 250 - 281 (2011). CAMCAM 0007-9235 http://dx.doi.org/10.3322/caac.v61:4
2. Weiss A., et al., " Angiogenesis inhibition for the improvement of photodynamic therapy: the revival of a promising idea.," BBA Rev. Cancer 1826 (1), 53 - 70 (2012). 0304-419X. http://dx.doi.org/10.1016/j.bbcan.2012.03. 003
3. Fotinos N., et al., " 5-Aminolevulinic acid derivatives in photomedicine: characteristics, application and perspectives.," Photochem. Photobiol. 82 (4), 994 - 1015 (2006). PHCBAP 0031-8655 http://dx.doi.org/10. 1562/2006-02-03-IR-794 (Pubitemid 44450185)
4. Radakovic-Fijan S., et al., " Efficacy of three different light doses in the treatment of actinic keratosis with 5-aminolevulinic acid photodynamic therapy: a randomized, observer-blinded, intrapatient, comparison study.," J. Am. Acad. Dermatol. 53 (5), 823 - 827 (2005). JAADDB 0190-9622 http://dx.doi.org/10.1016/j.jaad.2005.06.010 (Pubitemid 41501368)
5. Glanzmann T., et al., " Pharmacokinetics of tetra(m-hydroxyphenyl) chlorin in human plasma and individualized light dosimetry in photodynamic therapy.," Photochem. Photobiol. 67 (5), 596 - 602 (1998). PHCBAP 0031-8655 http://dx.doi.org/10.1562/0031-8655(1998)067<0596:POTHIH>2.3.CO;2 (Pubitemid 128472286)
6. Busch T. M., " Local physiological changes during photodynamic therapy.," Lasers Surg. Med. 38 (5), 494 - 499 (2006). LSMEDI 0196-8092 http://dx.doi.org/10.1002/(ISSN)1096-9101
7. Arabi M., Piert M., " Hypoxia PET/CT imaging: implications for radiation oncology.," Q. J. Nucl. Med. Mol. Imaging 54 (5), 500 - 509 (2010). 1824-4785
8. Moan J., Juzenas P., " Singlet oxygen in photosensitization.," J. Environ. Pathol. Toxicol. Oncol. 25 (1-2), 29 - 50 (2006). JEPOEC 0731-8898 http://dx.doi.org/10.1615/JEnvironPatholToxicolOncol.v25.i1-2 (Pubitemid 43341233)
9. Schmidt R., " Photosensitized generation of singlet oxygen.," Photochem. Photobiol. 82 (5), 1161 - 1177 (2006). PHCBAP 0031-8655 http://dx.doi.org/10.1562/2006-03-03-IR-833 (Pubitemid 44710772)
10. Niedre M. J., et al., " Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical aminolevulinic acid.," Br. J. Cancer 92 (2), 298 - 304 (2005). BJCAAI 0007-0920 http://dx.doi.org/10.1038/sj.bjc.6602331 (Pubitemid 40343145)
11. Kruijt B., et al., " Monitoring ALA-induced PpIX photodynamic therapy in the rat esophagus using fluorescence and reflectance spectroscopy.," Photochem. Photobiol. 84 (6), 1515 - 1527 (2008). PHCBAP 0031-8655 http://dx.doi.org/10.1111/php.2008.84.issue-6
12. Sheng C., et al., " Photobleaching-based dosimetry predicts deposited dose in ALA-PpIX PDT of rodent esophagus.," Photochem. Photobiol. 83 (3), 738 - 748 (2007). PHCBAP 0031-8655 http://dx.doi.org/10.1562/2006-09- 07-RA-1033 (Pubitemid 46854943)
13. Huang Z., " A review of progress in clinical photodynamic therapy.," Technol. Cancer Res. Treat. 4 (3), 283 - 293 (2005). 1533-0346 (Pubitemid 40807688)
14. Wilson B. C., Patterson M. S., Lilge L., " Implicit and explicit dosimetry in photodynamic therapy: a new paradigm.," Lasers Med. Sci. 12 (3), 182 - 199 (1997). LMSCEZ 1435-604X http://dx.doi.org/10.1007/BF02765099 (Pubitemid 27404122)
15. Nowak-Sliwinska P., et al., " Study of the pO2 -sensitivity of the dendrimeric and free forms of Pd-meso-tetra(4-carboxyphenyl)porphyrin, incorporated or not in chitosan-based nanoparticles.," Chimia 65 (9), 691 - 695 (2011). AFRCAQ
16. Wang K. K., et al., " Simulations of measured photobleaching kinetics in human basal cell carcinomas suggest blood flow reductions during ALA-PDT.," Lasers Surg. Med. 41 (9), 686 - 696 (2009). LSMEDI 0196-8092 http://dx.doi.org/10.1002/lsm.v41:9
17. Forrer M., et al., " In-vivo measurement of fluorescence bleaching of meso-tetra hydroxy phenyl chlorin (mthpc) in the oesophagus and the oral cavity.," Proc. SPIE 2627 (1), 33 - 39 (1995). PSISDG 0277-786X http://dx.doi.org/10.1117/12.228901
18. Hornung R., et al., " Systemic application of photosensitizers in the chick chorioallantoic membrane (CAM) model: photodynamic response of CAM vessels and 5-aminolevulinic acid uptake kinetics by transplantable tumors.," J. Photochem. Photobiol. B 49 (1), 41 - 49 (1999). JPPBEG 1011-1344 http://dx.doi.org/10.1016/S1011-1344(99)00014-7 (Pubitemid 29229675)
19. Nowak-Sliwinska P., et al., " Vascular regrowth following photodynamic therapy in the chicken embryo chorioallantoic membrane.," Angiogenesis 13 (4), 281 - 292 (2010). http://dx.doi.org/10.1007/s10456-010- 9185-x
20. Lange N., et al., " A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV.," Invest. Ophthalmol. Vis. Sci. 42 (1), 38 - 46 (2001). IOVSDA 0146-0404 (Pubitemid 32059408)
21. Mik E. G., et al., " Mitochondrial pO2 measured by delayed fluorescence of endogenous protoporphyrin IX.," Nat. Meth. 3 (11), 939 - 945 (2006). 1548-7091 http://dx.doi.org/10.1038/nmeth940 (Pubitemid 44614730)
22. Piffaretti F., et al., " Optical fiber-based setup for in vivo measurement of the delayed fluorescence lifetime of oxygen sensors.," J. Biomed. Opt. 16 (3), 037005 (2011). JBOPFO 1083-3668 http://dx.doi.org/10.1117/ 1.3558846
23. Redmond R. W., Gamlin J. N., " A compilation of singlet oxygen yields from biologically relevant molecules.," Photochem. Photobiol. 70 (4), 391 - 475 (1999). PHCBAP 0031-8655 http://dx.doi.org/10.1111/j.1751-1097. 1999.tb08240.x (Pubitemid 129555813)
24. Niedre M. J., et al., " Imaging of photodynamically generated singlet oxygen luminescence in vivo.," Photochem. Photobiol. 81 (4), 941 - 943 (2005). PHCBAP 0031-8655 http://dx.doi.org/10.1562/2005-03-15-TSN-462R.1 (Pubitemid 41268607)
25. Stepinac T. K., et al., " Light-induced retinal vascular damage by Pd-porphyrin luminescent oxygen probes.," Invest. Ophth. Vis. Sci. 46 (3), 956 - 966 (2005). IOVSDA 0146-0404 http://dx.doi.org/10.1167/iovs.04-0500 (Pubitemid 41321033)
26. Glanzmann T., et al., " Time-resolved spectrofluorometer for clinical tissue characterization during endoscopy.," Rev. Sci. Instr. 70 (10), 4067 - 4077 (1999). RSINAK 0034-6748 http://dx.doi.org/10.1063/1.1150038 (Pubitemid 129589052)
27. Mik E. G., et al., " Mitochondrial pO2 measured by delayed fluorescence of endogenous protoporphyrin IX.," Nat. Meth. 3 (11), 939 - 945 (2006). 1548-7091 http://dx.doi.org/10.1038/nmeth940 (Pubitemid 44614730)
28. Piffaretti F., et al., " Optical fiber-based setup for in vivo measurement of the delayed fluorescence lifetime of oxygen sensors.," J. Biomed. Opt. 16 (3), 037005 (2011). JBOPFO 1083-3668 http://dx.doi.org/10.1117/ 1.3558846
29. Marquardt D. W., " An algorithm for least-squares estimation of nonlinear parameters.," J. Soc. Indus. Appl. Math. 11 (2), 431 - 441 (1963). JSMCAL http://dx.doi.org/10.1137/0111030
30. More J., " The Levenberg-Marquardt algorithm: implementation and theory.," Numerl. Anal. 630 (105 - 116), (1978). LNMAA2 0075-8434 http://dx.doi.org/10.1007/BFb0067690
31. Mik E. G., et al., " Excitation pulse deconvolution in luminescence lifetime analysis for oxygen measurements in vivo.," Photochem. Photobiol. 76 (1), 12 - 21 (2002). PHCBAP 0031-8655 http://dx.doi.org/10.1562/0031- 8655(2002)0760012EPDILL2.0.CO2
32. Box G. E. P., Jenkins G. M., Reinsel G. C., " Time series analysis.," in Forecasting and Control, Hoboken N. J. W., Ed., pp. 746 - 755 (2008).
33. Fasso A., " Residual autocorrelation distribution in the validation data set.," J. Time Ser. Anal. 21 (2), 143 - 153 (2000). JTSADL 0143-9782 http://dx.doi.org/10.1111/jtsa.2000.21.issue-2
34. Hoppenheit C., et al., " Pharmacokinetics of the photosensitizers aminolevulinic acid and aminolevulinic acid hexylester in oro-facial tumors embedded in the chorioallantois membrane of a hen's egg.," Cancer Biother. Radiopharm. 21 (6), 569 - 578 (2006). 1084-9785 http://dx.doi.org/10.1089/cbr. 2006.21.569 (Pubitemid 46175694)
35. Hornung R., et al., " Systemic application of photosensitizers in the chick chorioallantoic membrane (CAM) model: photodynamic response of CAM vessels and 5-aminolevulinic acid uptake kinetics by transplantable tumors.," J. Photochem. Photobiol. B 49 (1), 41 - 49 (1999). JPPBEG 1011-1344 http://dx.doi.org/10.1016/S1011-1344(99)00014-7 (Pubitemid 29229675)
36. Hammer-Wilson M. J., et al., " Photodynamic parameters in the chick chorioallantoic membrane (CAM) bioassay for photosensitizers administered intraperitoneally (IP) into the chick embryo.," Photochem. Photobiol. Sci. 1 (9), 721 - 728 (2002). 1474-905X http://dx.doi.org/10.1039/b205471j (Pubitemid 37069790)
37. Lange N., et al., " A new drug-screening procedure for photosensitizing agents used in photodynamic therapy for CNV.," Invest. Ophthalmol. Vis. Sci. 42 (1), 38 - 46 (2001). IOVSDA 0146-0404 (Pubitemid 32059408)
38. Lim S. H., et al., " The neovessel occlusion efficacy of 15-hydroxypurpurin-7-lactone dimethyl ester induced with photodynamic therapy.," Photochem. Photobiol. 86 (2), 397 - 402 (2010). PHCBAP 0031-8655 http://dx.doi.org/10.1111/php.2010.86.issue-2
39. Lee S., et al., " Pulsed diode laser-based singlet oxygen monitor for photodynamic therapy: In vivo studies of tumor-laden rats.," J. Biomed. Opt. 13 (6), 064035 (2008). JBOPFO 1083-3668 http://dx.doi.org/10.1117/1. 3042265
40. Wilson B. C., Patterson M. S., " The physics, biophysics, and technology of photodynamic therapy.," Phys Med Biol 53 (9), R61 - 109 (2008). PHMBA7 0031-9155 http://dx.doi.org/10.1088/0031-9155/53/9/R01
41. Jarvi M. T., et al., " Singlet oxygen luminescence dosimetry (SOLD) for photodynamic therapy: current status, challenges and future prospects.," Photochem. Photobiol. 82 (5), 1198 - 1210 (2006). PHCBAP 0031-8655 http://dx.doi.org/10.1562/2006-05-03-IR-891 (Pubitemid 44701998)
42. Georgakoudi I., Foster T. H., " Singlet oxygen- versus nonsinglet oxygen-mediated mechanisms of sensitizer photobleaching and their effects on photodynamic dosimetry.," Photochem. Photobiol. 67 (6), 612 - 625, (1998). PHCBAP 0031-8655 http://dx.doi.org/10.1111/j.1751-1097.1998.tb09102.x (Pubitemid 128471939)
43. Castano A. P., Demidova T. N., Hamblin M. R., " Mechanisms in photodynamic therapy: Part 1-Photosensitizers, photochemistry, and cellular localization.," Photodiag. Photodyn. Ther. 1 (4), 279 - 293 (2004) http://dx.doi.org/10.1016/S1572-1000(05)00007-4 (Pubitemid 40460316)
44. Mik E. G., et al., " In vivo mitochondrial oxygen tension measured by a delayed fluorescence lifetime technique.," Biophys J. 95 (8), 3977 - 3990 (2008). BIOJAU 0006-3495 http://dx.doi.org/10.1529/biophysj.107.126094
45. Grote J., Susskind R., Vaupel P., " Oxygen diffusivity in tumor tissue (DS-carcinosarcoma) under temperature conditions within the range of 20-40°C.," Pflugers Arch. 372 (1), 37 - 42 (1977). (Pubitemid 8226017)
46. Moan J., Berg K., " The photodegradation of porphyrins in cells can be used to estimate the lifetime of singlet oxygen.," Photochem. Photobiol. 53 (4), 549 - 553 (1991). PHCBAP 0031-8655 http://dx.doi.org/10.1111/php.1991. 53.issue-4
47. Plaetzer K., et al., " Photophysics and photochemistry of photodynamic therapy: fundamental aspects.," Lasers Med. Sci. 24 (2), 259 - 268 (2009). LMSCEZ 1435-604X http://dx.doi.org/10.1007/s10103-008-0539-1
48. Ascencio M., et al., " Comparison of continuous and fractionated illumination during hexaminolaevulinate-photodynamic therapy.," Photodiag. Photodyn. Ther. 5 (3), 210 - 216 (2008). http://dx.doi.org/10.1016/j.pdpdt.2008. 09.004
49. Wang K. K., et al., " Irradiation-induced enhancement of Pc 4 fluorescence and changes in light scattering are potential dosimeters for Pc 4-PDT.," Photochem. Photobiol. 83 (5), 1056 - 1062 (2007). PHCBAP 0031-8655 http://dx.doi.org/10.1111/php.2007.83.issue-5 (Pubitemid 47438513)
50. Uehlinger P., et al., " On the role of iron and one of its chelating agents in the production of protoporphyrin IX generated by 5-aminolevulinic acid and its hexyl ester derivative tested on an epidermal equivalent of human skin.," Photochem. Photobiol. 82 (4), 1069 - 1076 (2006). PHCBAP 0031-8655 http://dx.doi.org/10.1562/2005-12-04-RA-745 (Pubitemid 44450194)
51. Nowak-Sliwinska P., et al., " Processing of fluorescence angiograms for the quantification of vascular effects induced by anti-angiogenic agents in the CAM model.," Microvasc. Res. 79 (1), 21 - 28 (2010). MIVRA6 0026-2862 http://dx.doi.org/10.1016/j.mvr.2009.10.004
52. Debefve E., et al., " Video monitoring of neovessel occlusion induced by photodynamic therapy with verteporfin (Visudyne), in the CAM model.," Angiogenesis 11 (3), 235 - 243 (2008). http://dx.doi.org/10.1007/ s10456-008-9106-4
53. Foster T. H., et al., " Oxygen consumption and diffusion effects in photodynamic therapy.," Radiat. Res. 126 (3), 296 - 303 (1991). RAREAE 0033-7587 http://dx.doi.org/10.2307/3577919
54. Nathan A. T., Singer M., " The oxygen trail: tissue oxygenation.," Br. Med. Bull. 55 (1), 96 - 108 (1999). BMBUAQ 0007-1420 http://dx.doi.org/10.1258/0007142991902312 (Pubitemid 29243552)
55. Schunck T., Poulet P., " Oxygen consumption through metabolism and photodynamic reactions in cells cultured on microbeads.," Phys. Med. Biol. 45 (1), 103 - 119 (2000). PHMBA7 0031-9155 http://dx.doi.org/10.1088/0031-9155/ 45/1/308 (Pubitemid 30060663)
56. Plaetzer K., et al., " Photophysics and photochemistry of photodynamic therapy: fundamental aspects.," Lasers Med. Sci. 24 (2), 259 - 268 (2009). LMSCEZ 1435-604X http://dx.doi.org/10.1007/s10103-008-0539-1
57. Cruess A. F., et al., " Photodynamic therapy with verteporfin in age-related macular degeneration: a systematic review of efficacy, safety, treatment modifications, and pharmacoeconomic properties.," Acta. Ophthalmol. 87 (2), 118 - 132 (2009). ACOPAT 0001-639X http://dx.doi.org/10. 1111/aos.2009.87.issue-2